General European OMCL Network (GEON) Quality Management Document
General European OMCL Network (GEON) Quality Management Document
PA/PH/OMCL (20) 21 R1
N.B. This OMCL Quality Management System document is applicable to members of the European
OMCL Network only. Other laboratories might use the document on a voluntary basis. However,
please note that the EDQM cannot treat any questions related to the application of the documents
submitted by laboratories other than the OMCLs of the Network.
PA/PH/OMCL (20) 21 R1 – Risk-based Auditing Approach
1. INTRODUCTION
The overall common objective of the European Regulatory Network is to ensure the health and well-
being of patients and protect public health through medicinal products of high quality that are safe
and effective. OMCLs contribute to this objective by testing the quality of medicines on the market
(legal or illegal) and by producing reliable test results as a basis for adequate decision-making by the
competent authority. However, risks to patients or to public health can often only be estimated within
a specific context. This Guidance therefore focuses on the risks to the validity of reported test results.
Application of a risk-based approach in auditing is primarily aimed at the identification of risk factors.
This includes the careful selection of methodologies that are representative of the laboratory’s scope
to ensure confidence in the conformity of the laboratory with the requirements of ISO/IEC 17025,
OMCL Guidelines and the Ph. Eur. This risk-based identification and selection should follow a
structured approach for planning and conducting audits. It should also be applicable to all laboratories
and include additional ad hoc elements, e.g. randomly selected and/or new topics under the scope.
This Guidance can support the audit team in the preparation of the MJA schedule, whenever the
concept of risk-based auditing becomes necessary. The Guidance does not have a prescriptive
character.
Application of a risk-based approach in audits is focused on identifying risk-based methodologies to
attain the necessary confidence of the conformity of the lab with the requirements of ISO/IEC 17025,
OMCL Guidelines and Ph. Eur. requirements.
Reduction of the scope of the technical audit should not be applied in cases where the full scope can
be covered within the normal time frame (usually two days of assessment). However, in the event of
a large scope involving different lab units and/or a wide instrument park, the considerations presented
in this Guidance should be taken into account during the preparation of the audit schedule.
Regarding the quality system, all clauses of ISO/IEC 17025 shall be covered in an audit; therefore the
quality system is out of the scope of this document.
3. DEFINITIONS/GLOSSARY
Audit scope: extent and boundaries of an audit.
Audit criteria: reference against which conformity is determined, e.g. applicable standard, policies,
procedures, regulatory requirements, performance criterial including objective.
Risk-based approach: an audit approach that considers risk and opportunities. The risk-based
approach should substantively influence the planning, conducting and reporting of audits in order to
ensure that audits are focused on matters that are significant for OMCL function.
For the audit of the quality system, all clauses of ISO/IEC 17025 shall be covered in an audit.
p. 2/8
PA/PH/OMCL (20) 21 R1 – Risk-based Auditing Approach
For the technical audit, this Guidance identifies several typical risk factors that shall be addressed
during an audit. The list of risk factors provided in section 6 should not be considered exhaustive, and
not all risk factors are applicable to all OMCLs.
Electrophoresis SDS-PAGE
Blotting
Physical Dissolution test • different dosage forms/apparatus
Gravimetry • different precision requirements
Volumetry • excl. volumetric titration (see below)
Visual determination Appearance • incl. semi-quantitative determination of
coloration/opalescence
Optical microscopy
Fluorimetry
p. 3/8
PA/PH/OMCL (20) 21 R1 – Risk-based Auditing Approach
Coagulation Chromogenic
Clotting time
Vaccine potency Virus titration • all detection techniques in use (visual, staining,
antibody staining, NAT, etc.)
Risk factors that contribute to the validity of reported test results are depicted in the fishbone diagram
below and further discussed in Table 2, including the points to be checked during the audit. The list
below is not comprehensive and, unless indicated, is not given in priority order.
The management of these and some additional risk factors are addressed by OMCL Quality
Management Guidelines or Recommendation Documents.
p. 4/8
PA/PH/OMCL (20) 21 R1 – Risk-based Auditing Approach
Table 2. Risk factors that contribute to the validity of reported test results and points to be checked during the audit.
Reference Substances GL Handling and Use of Non- • Reference substances obtained from marketing authorisation holders (MAH)
Compendial Reference • Reference substances obtained by purchasing from commercial sources
Standards in the OMCL • Use of reference substances outside the intended scope (e.g. storage and re-use of
Network aliquots)
• Secondary in-house reference substances established by the OMCL
Computerised systems GL Computerised Systems & • Management of installation and updates of (commercial) equipment software
Annexes • Self-developed Excel spreadsheets
• Complex systems (LIMS validation)
p. 5/8
PA/PH/OMCL (20) 21 R1 – Risk-based Auditing Approach
Sample Management GL Management of Samples Prioritisation acc. to risk factors from matrix/required sample preparation:
• unknown > complex (e.g. ointments, herbals) > solution
• product-specific storage conditions
Ensuring validity of results ISO/IEC 17025 7.7 (no • PTS participation (see last management review) and failure management
additional OMCL requirements) • Laboratory comparisons other than PTS (collaborative studies)
• Use of Control charts
• Blind samples
Triggers for method selection:
• No PTS participation or poor PTS performance
• Not covered by NAB accreditation
• Not covered by previous MJA
• Other approaches
p. 6/8
PA/PH/OMCL (20) 21 R1 – Risk-based Auditing Approach
Evaluation and reporting of GL Evaluation and reporting of • Traceability of technical records (including calculations, transcription and checks).
results results • Decision rules in case of conformity assessment
GL Management of documents • OOS Verification/investigation/decisions and effectiveness of actions
and records • Test reports
ISO/IEC 17025 clause (clause • Interpretations and decisions based on test results (assessment, OCABR certificates, etc.)
7.8)
p. 7/8
PA/PH/OMCL (20) 21 R1 – Risk-based Auditing Approach
7. RESPONSIBILITIES
The audit team is responsible for the risk-based selection of audit items.
However, the audited laboratory should contribute by providing the necessary information to support a
meaningful method selection during the preparation phase, when applicable.
Risk-based selection of the methods will be defined before the audit, and any change discussed/agreed with
the audited lab.
8. REFERENCES
1) ISO 19011:2018 for auditing management systems, clauses 4.g), 6.3.2.1., 6.3.2.2.h)
2) ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories
3) OMCL Quality Management Guidelines and Recommendation Documents
p. 8/8